Hideyuki Furumoto

MedicineEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models”.

Simultaneously Combined Cancer Cell- and CTLA4-Targeted NIR-PIT Causes a Synergistic Treatment Effect in Syngeneic Mouse Models

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0470

N/A

0DataRank · unranked

34 citations

Ryuhei Okada, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Electron Donors Rather Than Reactive Oxygen Species Needed for Therapeutic Photochemical Reaction of Near-Infrared Photoimmunotherapy

ACS Pharmacology & Translational Science(2021)10.1021/acsptsci.1c00184

N/A

0DataRank · unranked

31 citations

Ryuhei Okada, Yuto Goto, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama +9 more

Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model

Cancer Science(2021)10.1111/cas.15013

N/A

0DataRank · unranked

25 citations

Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Shuhei Okuyama +5 more

Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

Cancer Immunology Research(2022)10.1158/2326-6066.cir-22-0041

N/A

0DataRank · unranked

53 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Near-Infrared Photoimmunotherapy Targeting Podoplanin-Expressing Cancer Cells and Cancer-Associated Fibroblasts

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0313

N/A

0DataRank · unranked

31 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model

OncoImmunology(2022)10.1080/2162402x.2021.2019922

N/A

0DataRank · unranked

30 citations

Ryuhei Okada, Fuyuki Inagaki, Hiroaki Wakiyama, Takuya Kato, Hideyuki Furumoto +5 more

Intercellular adhesion molecule‐1‐targeted near‐infrared photoimmunotherapy of triple‐negative breast cancer

Cancer Science(2022)10.1111/cas.15466

N/A

0DataRank · unranked

24 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Selective depletion of polymorphonuclear myeloid derived suppressor cells in tumor beds with near infrared photoimmunotherapy enhances host immune response

OncoImmunology(2022)10.1080/2162402x.2022.2152248

N/A

0DataRank · unranked

24 citations

Hiroshi Fukushima, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +5 more

Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy

Cancer Immunology Immunotherapy(2022)10.1007/s00262-021-03124-x

N/A

0DataRank · unranked

22 citations

Takuya Kato, Aki Furusawa, Fuyuki Inagaki, Hiroaki Wakiyama, Daiki Fujimura +6 more

Opening up new VISTAs: V-domain immunoglobulin suppressor of T cell activation (VISTA) targeted near-infrared photoimmunotherapy (NIR-PIT) for enhancing host immunity against cancers

Cancer Immunology Immunotherapy(2022)10.1007/s00262-022-03205-5

N/A

0DataRank · unranked

14 citations

Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Takuya Kato, Hideyuki Furumoto +5 more

Disialoganglioside GD2-Targeted Near-Infrared Photoimmunotherapy (NIR-PIT) in Tumors of Neuroectodermal Origin

Pharmaceutics(2022)10.3390/pharmaceutics14102037

N/A

0DataRank · unranked

11 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Hiroaki Wakiyama, Hideyuki Furumoto +4 more

Comparison of the Effectiveness of IgG Antibody versus F(ab′)2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy

Molecular Pharmaceutics(2022)10.1021/acs.molpharmaceut.2c00242

N/A

0DataRank · unranked

8 citations

Ryuhei Okada, Aki Furusawa, Hiroaki Wakiyama, Hideyuki Furumoto, Hiroshi Fukushima +4 more

Endoscopic Applications of Near-Infrared Photoimmunotherapy (NIR-PIT) in Cancers of the Digestive and Respiratory Tracts

Biomedicines(2022)10.3390/biomedicines10040846

N/A

0DataRank · unranked

9 citations

Takuya Kato, Hiroaki Wakiyama, Aki Furusawa, Peter L. Choyke, Hisataka Kobayashi +1 more

Data from Treg-Dominant Tumor Microenvironment Is Responsible for Hyperprogressive Disease after PD-1 Blockade Therapy

(2023)10.1158/2326-6066.c.6551037

N/A

0DataRank · unranked

0 citations

Takuya Kato, Aki Furusawa, Ryuhei Okada, Fuyuki Inagaki, Hideyuki Furumoto +5 more

Preserved host immunity with intercellular adhesion molecule-1 (ICAM-1)-targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of triple-negative breast cancer and other malignancies

Cancer Letters(2025)10.1016/j.canlet.2025.217906

N/A

0DataRank · unranked

3 citations

Hideyuki Furumoto, Aki Furusawa, Makoto Kano, Hiroshi Yamamoto, Motofumi Suzuki +4 more